Carina Namih

Partner at Plural · Joined 2023

View Live Interactive Profile →

Biography

Carina Namih is a partner at Plural, which she joined in March 2023. She co-founded HelixNano in San Francisco in 2013 at age 23 and led it as Chief Executive Officer, applying AI to RNA and raising backing from investors including Sam Altman and Eric Schmidt, with the company now running trials in treatment-resistant cancers. Between 2018 and the summer of 2022 she did B2B seed-stage investing as a general partner with the UK fund Episode 1, and she serves on the board of The Alan Turing Institute. Her listed investments at Plural include Sunrise Robotics, Softmax, Molyon and Upside Robotics.

Previous Experience

Notable Investments

Sunrise RoboticsSoftmaxMolyonUpside RoboticsRobin AISano Genetics

Board Seats

Career Timeline

2013
Co-founded HelixNano in San Francisco at age 23 and served as its Chief Executive Officer.
2018
Began B2B seed-stage investing as a general partner with UK fund Episode 1.
2023
Joined Plural, announced on 23 March 2023.
null
Serves as a board member of The Alan Turing Institute.

Sources & References

Plural - Carina Namih ↗Plural - Why We Invested in Sunrise Robotics ↗Plural - Why We Invested in Upside Robotics ↗The Alan Turing Institute - Carina Namih, Board of Trustees ↗TechCrunch - Plural lures mRNA vaccine and AI pioneer to become its newest partner ↗